Explore our core engineering catalog designed for clinical validation, laboratory settings, and high-performance industrial applications.
A global leader in decentralized clinical trial solutions, remote monitoring technologies, and precision electronic product manufacturing.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations (CROs), pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment (eCOA) solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. In addition to its standard product offerings, the company provides OEM and ODM services tailored to specific research applications and market requirements.
Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, Dongguan Trial Medical Co., Ltd. is committed to advancing digital clinical research through innovative technologies that support decentralized studies, patient-centric trial models, and data-driven healthcare innovation worldwide.
Analyzing key structural shifts and device requirements for Decentralized Clinical Trials (DCT) and remote health research.
Global pharmaceutical sponsors and CROs demand end-to-end encryption (AES-256) and strict compliance with HIPAA and GDPR. Every home-based trial device must support secure data transmission pipelines directly to centralized eCRF databases without middleman vulnerability.
Unlike consumer fitness trackers, home-based clinical equipment requires validation against golden standards. Procurement teams mandate rigorous clinical study data proving accuracy limits match or exceed standard in-clinic instruments.
Modern trials reject closed ecosystems. Advanced procurement specifications mandate RESTful APIs, HL7/FHIR compatibility, and SDK packages that allow direct integration into proprietary eCOA (electronic Clinical Outcome Assessment) and CTMS systems.
Bridging the gap between physical hardware manufacturing and digital clinical trial execution.
The global shift toward Decentralized Clinical Trials (DCTs) has exposed significant bottlenecks in supply chain and device configuration. Standard consumer electronics lack the validation protocols required by regulatory bodies like the FDA, EMA, and NMPA. In response, advanced medical equipment manufacturers have transitioned from basic manufacturing to providing integrated, holistic macro solutions that align hardware with software and logistics.
Providing ready-to-use patient kits containing all necessary diagnostic devices (e.g., blood pressure monitors, spirometers, temperature loggers, and tablets) pre-paired, calibrated, and configured to minimize user error during trials.
Ensuring compliance with local environmental and biohazard regulations for returns, refurbishment, recalibration, and secure data sanitization of home-use devices between patient clinical cohorts.
Leveraging cellular-enabled hubs and Bluetooth Low Energy (BLE) protocols to stream high-frequency biological telemetry back to clinical databases, preventing data loss from poor internet connections.
Dongguan Trial Medical Co., Ltd. addresses these macro bottlenecks by developing vertical configurations that combine smart electronic manufacturing with custom software setups. By keeping manufacturing and testing in-house inside their 11,000 m² state-of-the-art facility, they significantly compress the design-to-validation timeline, offering CROs pre-certified hardware ready for direct integration.
Mapping the next decade of decentralized patient diagnostic and remote clinical technology.
By computing parameters on-device, next-generation wearable and home-based trial equipment can instantly flag data anomalies, severe patient health warnings, or device misuse without waiting for cloud processing. This reduces network data payload demands and improves immediate patient safety outcomes.
Future iterations of clinical trial monitors will shift away from single-metric monitoring (e.g., just heart rate) toward unified multi-sensor patches. These devices will simultaneously process oxygen saturation, continuous core temperature, ECG, and respiratory dynamics to deliver context-rich bio-telemetry.
To eliminate data fabrication concerns in at-home clinical studies, next-generation device firmware will directly generate cryptographic keys. These keys sign recorded data packets at the point of origin, creating immutable logs for FDA audits under ALCOA+ data integrity guidelines.
Ensuring global market access through rigorous adherence to international medical and electronic standards.
Developing hardware for clinical research requires strict alignment with localized healthcare jurisdictions. Manufacturers must verify not only the electronic safety of the devices but also the integrity of data structures. The table below highlights the global regulatory standards integrated into the Dongguan Trial Medical manufacturing processes:
Specifies requirements for electronic records, electronic signatures, and secure audit trails to ensure digital clinical data matches the reliability of paper records.
Governs quality management systems (QMS) specifically for medical device manufacturing, guaranteeing material safety and manufacturing consistency globally.
Mandates patient privacy protection. Direct wireless transmission from devices to clinical endpoints must anonymize patient health information (PHI).
Key information regarding procurement, customization, regulatory standards, and logistics for home-based trial equipment.
In-house manufacturing excellence, quality control lines, and advanced diagnostics integration.
Explore our additional hardware catalog covering analysis, communications, and green power solutions.
Trial Medical
